Crinetics Pharmaceuticals, Inc.
SEC CIK 1658247 · CRNX · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wierenga Wendell | Director | filed 2026 - 2026 |
| Bedrosian Camille L | Director | filed 2020 - 2026 |
| Fust Matthew K | Director | filed 2018 - 2026 |
| Vivaldi Coelho Rogerio | Director | filed 2022 - 2026 |
| Okey Stephanie | Director | filed 2019 - 2026 |
| Nichols Weston | Director | filed 2018 - 2026 |
| Deardorf Caren | Director | filed 2022 - 2026 |
| Struthers Richard Scott | Director · See Remarks | filed 2018 - 2026 |
| Wierenga Wendall | Director | filed 2018 - 2025 |
| Perceptive Advisors LLC | Director | filed 2018 - 2022 |
| Perceptive Life Sciences Master Fund LTD | Director | filed 2018 - 2022 |
| Kaldor Stephen W | Director | filed 2018 - 2020 |
| Nielsen Jack | Director | filed 2018 - 2019 |
| Freeman Mason | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Knight Jeff E. | Chief Operating Officer | filed 2021 - 2026 |
| Betz Stephen F. | Chief Scientific Officer | filed 2021 - 2026 |
| Schilke Tobin | Chief Financial Officer | filed 2025 - 2026 |
| Kalofonos Isabel | Chief Commercial Officer | filed 2024 - 2026 |
| Pizzuti Dana | Chief Med and Dev Officer | filed 2022 - 2025 |
| Wilson Marc | See Remarks | filed 2018 - 2025 |
| Hassard James | Chief Commercial Officer | filed 2022 - 2024 |
| Krasner Alan Seth | Chief Medical Officer | filed 2018 - 2023 |
| Madan Ajay | Chief Development Officer | filed 2020 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.